SRG-514
/ SURGE Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 09, 2024
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: SURGE Therapeutics | N=18 ➔ 24
Enrollment change • Surgery • Breast Cancer • Oncology • Solid Tumor
June 04, 2024
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: SURGE Therapeutics | Not yet recruiting ➔ Recruiting
Enrollment open • Surgery • Breast Cancer • Oncology • Solid Tumor
March 13, 2024
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: SURGE Therapeutics
New P1 trial • Surgery • Breast Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1